PROSTATE CANCER WITH A HIGH BASELINE PSA LEVEL AFTER COMBINED TREATMENT

by A. T. Asratov, A. S. Kalpinskiy, I. A. Taraki, Yu. V. Samsonov, A. A. Kostin
Published 2017-12-01

Optimization of sequential targeted therapy

by B. Ya. Alekseev, A. S. Kalpinskiy, K. M. Nyushko, I. A. Taraki, A. D. Kaprin
Published 2016-09-01

Anatomy of the neurovascular bundle and methods of its preservation with nerve-sparing prostatectomy

by H. S. Gevorgyan, A. A. Kostin, N. V. Vorobyev, K. М. Nyushko, A. G. Muradyan, I. A. Taraki, Y. V. Samsonov
Published 2018-09-01

POSSIBILITIES OF ORGAN-PRESERVING TREATMENT OF PATIENTS WITH MULTIPLE RENAL TUMORS

by B. Ya. Alekseev, A. S. Kalpinskiy, I. A. Taraki, A. A. Mukhomed’yarova, K. М. Nyushko, N. V. Vorobyev, A. A. Kostin, A. D. Kaprin
Published 2017-06-01

NEOADJUVANT AND ADJUVANT CHEMOHORMONAL THERAPY IN PATIENTS WITH HIGH-RISK AND VERY HIGH-RISK PROSTATE CANCER: OUR EXPERIENCE

by T. V. Ustinova, K. M. Nyushko, L. V. Bolotina, N. V. Kharchenko, A. A. Paychadze, I. A. Taraki, B. Ya. Alekseev, A. A. Krasheninnikov, A. D. Kaprin
Published 2018-10-01